With the analysis among 1,809 patents, we discovered top 118 key players by total patent application. AbbVie, Inc., GlaxoSmithKline Intellectual Property (No. 2) Ltd., GlaxoSmithKline LLC are dominant in this area. They take 30.46% of the total patent filing.
Illinois, United States
Patent: 212
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
United Kingdom
Patent: 145
Pennsylvania, United States
Patent: 114
Constellation Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 110
California, United States
Patent: 66
California, United States
Patent: 44
Massachusetts, United States
Patent: 43
Massachusetts, United States
Patent: 40
With the analysis among 28 patents, we discovered top 5 start-ups by total patent application. TOLREMO therapeutics AG, Institut National de la Santé et de la Recherche Médicale, Stemirna Therapeutics Co. Ltd. are active in this area.
ZURICH, Switzerland
Patent: 10
Institut National de la Santé et de la Recherche Médicale
Stemirna Therapeutics Co. Ltd.
Shanghai Shi, China
Patent: 5
California, United States
Patent: 1
With the analysis among related 584 patents applied in the last 5 years. We discover 123 most active companies in this area. The fast-growing Dana-Farber Cancer Institute, Inc., FORMA Therapeutics, Inc., GlaxoSmithKline Intellectual Property (No. 2) Ltd. take 19.52% of patent filing during this period.
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 40
Massachusetts, United States
Patent: 38
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
Illinois, United States
Patent: 30
Basel-Stadt, Switzerland
Patent: 24
Beijing Jiakesi New Drug Development Co. Ltd.
Beijing Shi, China
Patent: 21
New York, United States
Patent: 21
Shanghai Haihe Pharmaceutical Research & Development Co., Ltd.
Shanghai Shi, China
Patent: 16
Betta Pharmaceuticals Co., Ltd.
Zhejiang Sheng, China
Patent: 16
With the analysis among related 584 patents in last 5 years, we discover 61 new entrants. Novartis AG, Beijing Jiakesi New Drug Development Co. Ltd., Nuvation Bio, Inc. are the most active new entrants in this area.
Basel-Stadt, Switzerland
Patent: 24
Beijing Jiakesi New Drug Development Co. Ltd.
Beijing Shi, China
Patent: 21
New York, United States
Patent: 21
Shanghai Haihe Pharmaceutical Research & Development Co., Ltd.
Shanghai Shi, China
Patent: 16
Betta Pharmaceuticals Co., Ltd.
Zhejiang Sheng, China
Patent: 16
ZURICH, Switzerland
Patent: 10
Chengdu Easton Biopharmaceuticals Co., Ltd.
Sichuan Sheng, China
Patent: 7
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Hebei Sheng, China
Patent: 6
Nanjing Mingde New Drug Research and Development Co., Ltd.
Jiangsu Sheng, China
Patent: 6
Stemirna Therapeutics Co. Ltd.
Shanghai Shi, China
Patent: 5
With the analysis among 283 patents, we discovered top 41 universities and scientific research institutions by total patent application. Icahn School of Medicine at Mount Sinai, Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of Massachusetts are dominant in this area. They take 35.69% of the total patent filing.
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 23
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 17
University of Massachusetts
Massachusetts, United States
Patent: 10
DUNDEE, United Kingdom
Patent: 8
The Salk Institute for Biological Studies
California, United States
Patent: 8
Washington University in St. Louis
Missouri, United States
Patent: 6
Université d'Aix-Marseille
Connecticut, United States
Patent: 4
The Johns Hopkins University
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 4